Letter to the Editor: New confounders emerging with new evidence regarding reduced HCC and improved survival-Reference-Cited by-同舟云学术

Letter to the Editor: New confounders emerging with new evidence regarding reduced HCC and improved survival

Published:2024-06-05 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Hu Yue¹^ORCID,Li Zheng²^ORCID,Li Qiang³^ORCID,Jin Xiaodong³^ORCID,Di Cuixia³^ORCID,He Weilan¹,Cheng Xinran¹

Affiliation:

1. Department of Paediatric Genetics, Endocrinology and Metabolism, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

2. Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

3. Biomedical Center, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis;Jeng;Hepatology,2024

2. Association of metformin use and cancer incidence: A systematic review and meta-analysis;O’Connor;J Natl Cancer Inst,2024

3. Clinical outcomes with metformin use in diabetic patients with compensated cirrhosis: A systematic review and meta-analysis;Peppas;Eur J Gastroenterol Hepatol,2024

4. Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes;Yen;Clin Gastroenterol Hepatol,2023

5. Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes;Wang;Gastroenterology,2024

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival;Hepatology;2024-06-05